Greer BE, Koh WJ, Abu-Rustem NR et al. . NCCN Clinical Practice Guidelines in Oncology for Uterine Neoplasms. Version 2, 2012. Available at: http://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf. Accessed March 1, 2012.
Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212–236.
Lee NK, Cheung MK, Shin JY et al. . Prognostic factors for uterine cancer in reproductive-aged women. Obstet Gynecol 2007;109:655–662.
Creasman W, Odicino F, Maisonneuve P et al. . Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006;95(Suppl 1):S105–143.
Benedt JL, Bender H, Jones H et al. . FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO committee on gynecologic oncology. Int J Gynaecol Obset 2000;70:209–262.
Roper B, Astner ST, Heydemann-Obradovic A et al. . Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external radiotherapy in low and intermediate risk patients. Gynecol Oncol 2007;107:541–548.
Strughn JM Jr, Huh WK, Kelly FJ et al. . Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol 2002;84:194–200.
Morrow CP, Bundy BN, Kurman RJ et al. . Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991;40:50–65.
Keys HM, Roberts JA, Brunetto VL et al. . A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:744–751.
Creutzberg CL, Van Putten WL, Koper PC et al. . For the PORTEC Study Group: surgery and postoperative radiotherapy versus surgery alone for patients with stage-I endometrial carcinoma: multicentre randomised trial. Lancet 2000;355:1404–1411.
Ackerman I, Malone S, Thomas G et al. . Endometrial carcinoma-relative effectiveness of adjuvant irradiation vs therapy reserved for salvage. Gynecol Oncol 1996;60:177–183.
Creutzberg CL, van Putten WL, Koper PC et al. . For the PORTEC Study Group: survival after relapse in patients with endometrial cancer. Results from a randomised trial. Gynecol Oncol 2003;89:201–209.
Lin LL, Grigsby PW, Powell MA, Mutch DG. Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer. Int J Radiat Oncol Biol Phys 2005;63:500–504.